Correlation of antioxidative properties and vaso-relaxation effects of major active constituents of traditional Chinese medicines

References

• Ballew JR, Fink GD (2001): Characterization of the antihypertensive effect of a thiazide diuretic in angiotensin II-induced hypertension. J Hypertens 19: 1601–1606.
   PubMed Web of Science ®Google Scholar
• Blokhina O, Virolainen E, Fagerstedt KV (2003): Antioxidants, oxidative damage and oxygen deprivation stress: A review. Ann Bot (London) 91: 179–194.
   PubMed Web of Science ®Google Scholar
• Cao YX, Zhang W, He JY, He LC, Xu CB (2006): Ligustilide induces vasodilatation via inhibiting voltage dependent calcium channel and receptor-mediated Ca2+ influx and release. Vascul Pharmacol 45: 171–176.
   PubMed Web of Science ®Google Scholar
• Ciesielska E, Gwardys A, Metodiewa D (2002): Anticancer, antiradical and antioxidative actions of novel Antoksyd S and its major components, baicalin and baicalein. Anticancer Res 22: 2885–2891.
   PubMedGoogle Scholar
• Damiani CE, Rossoni LV, Vassallo DV (2003): Vasorelaxant effects of eugenol on rat thoracic aorta. Vascul Pharmacol 40:59–66.
   PubMed Web of Science ®Google Scholar
• Gardon M, Raizada MK, Katovich MJ, Berecek KH, Gelband CH (2000): Gene therapy for hypertension and restenosis. J Renin Angiotensin Aldosterone Syst 1: 211–216.
   PubMedGoogle Scholar
• Griendling KK, Sorescu D, Ushio-Fukai M (2000): NAD(P)H oxidase: Role in cardiovascular biology and disease. Circ Res 86: 494–501.
   PubMed Web of Science ®Google Scholar
• Huang Y, Wong CM, Lau CW, Yao X, Tsang SY, Su YL, Chen ZY (2004): Inhibition of nitric oxide/cyclic GMP-mediated relaxation by purified flavonoids, baicalin and baicalein, in rat aortic rings. Biochem Pharmacol 67: 787–794.
   PubMedGoogle Scholar
• Li WY, Chan SW, Guo DJ, Yu HF (2007): Correlation between antioxidative power and anticancer activity in herbs from traditional Chinese medicine formulae with anticancer therapeutic effect. Pharm Biol 45: 1–6.
   Google Scholar
• Li Y (2005): A clinical study on haunglian fire-purging mixture in treatment of 46 cases of primary hypertension. J Tradit Chin Med 25: 29–33.
   PubMedGoogle Scholar
• Liu QY, Li B, Gang JM, Karpinski E, Pang PK (1995): Tetrandrine, a Ca++ antagonist: Effects and mechanisms of action in vascular smooth muscle cells. J Pharmacol Exp Ther 273: 32–39.
   PubMedGoogle Scholar
• Ng TB, Liu F, Wang ZT (2000): Antioxidative activity of natural products from plants. Life Sci 66: 709–723.
   PubMed Web of Science ®Google Scholar
• Oettl K, Greilberger J, Zangger K, Haslinger E, Reibnegger G, Jürgens G (2001): Radical-scavenging and iron-chelating properties of carvedilol, an antihypertensive drug with antioxidative activity. Biochem Pharmacol 62: 241–248.
   PubMed Web of Science ®Google Scholar
• Qu ZC (2005): Progress of the Rhodiola herb. Chin J Pract Chin Mod Med 18: 1063–1066.
   Google Scholar
• Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG (1996): Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97: 1916–1923.
   PubMed Web of Science ®Google Scholar
• Redón J, Oliva MR, Tormos C, Giner V, Chaves J, Iradi A, Sáez GT (2003): Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 41:1096–1101.
   PubMed Web of Science ®Google Scholar
• Schlesier K, Harwat M, Bohm V, Bitsch R (2002): Assessment of antioxidant activity by using different in vitro methods. Free Radic Res 36: 177–187.
   PubMed Web of Science ®Google Scholar
• Seifried HE, Anderson DE, Fisher EI, Milner JA (2007): A review of the interaction among dietary antioxidants and reactive oxygen species. J Nutr Biochem 18: 567–579.
   PubMed Web of Science ®Google Scholar
• Shi JS, Yu JX, Chen XP, Xu RX (2003): Pharmacological actions of Uncaria alkaloids, rhynchophylline and isorhynchophylline. Acta Pharmacol Sin 24: 97–101.
   PubMed Web of Science ®Google Scholar
• Shu B, Zhou CJ, Ma YH, Wang YJ, Shi Q (2006): Research progress on pharmacological activities of the available compositions in Chinese medicinal herb Ligusticum chuanxiong. Chin Pharmacol Bull 22: 1043–1047.
   Google Scholar
• Skalska A, Gasowski J, Stepniewski M, Grodzicki T (2005): Antioxidative protection in hypertensive patients treated with diuretics. Am J Hypertens 18: 1130–1132.
   PubMed Web of Science ®Google Scholar
• Uehara Y, Kawabata Y, Shirahase H, Wada K, Hashizume Y, Morishita S, Numabe A, Iwai J (1993): Oxygen radical scavengers and renal protection by indapamide diuretic in salt-induced hypertension of Dahl strain rats. J Cardiovasc Pharmacol 22: S42–S46.
   Google Scholar
• Wang B, Zhang JD, Wang SH (2006): Effects of Qindan capsule on blood pressure, endothelin, calcitonin gene-related peptide and angiotensin- II in spontaneous hypertensive rats. Chin J Integr Med 12: 287–291.
   PubMedGoogle Scholar
• Wang CZ, Xie JT, Zhang B, Ni M, Fishbein A, Aung HH, Mehendale SR, Du W, He TC, Yuan CS (2007): Chemopreventive effects of Panax notoginseng and its major constituents on SW480 human colorectal cancer cells. Int J Oncol 31: 1149–1156.
   PubMed Web of Science ®Google Scholar
• Wang G, Lemos JR (1995): Tetrandrine: A new ligand to block voltage-dependent Ca2+ and Ca2+-activated K+ channels. Life Sci 56: 295–306.
   PubMedGoogle Scholar
• Wong KK (1998): Differential effect of tetrandrine on aortic relaxation and chronotropic activity in rat isolated aorta and atria. Planta Med 64: 663–665.
   PubMedGoogle Scholar
• Woo KJ, Lim JH, Suh SI, Kwon YK, Shin SW, Kim SC, Choi YH, Park JW, Kwon TK (2006): Differential inhibitory effects of baicalein and baicalin on LPS-induced cyclooxygenase-2 expression through inhibition of C/EBPbeta DNA-binding activity. Immunobiology 211: 359–368.
   PubMed Web of Science ®Google Scholar
• World Health Organization, International Society of Hypertension Writing Group (2003): 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21: 1983–1992.
   PubMed Web of Science ®Google Scholar
• Xiao JG, Chiou GC (1996): Tetrandrine inhibits breakdown of blood-aqueous barrier induced by endotoxin and interleukin-1 alpha in rats. J Ocul Pharmacol Ther 12: 323–329.
   PubMedGoogle Scholar
• Yan LP, Chan SW, Chan ASC, Chen SL, Ma XJ, Xu HX (2006): Puerarin decreases serum total cholesterol and enhances thoracic aorta endothelial nitric oxide synthase expression in diet-induced hypercholesterolemic rats. Life Sci 79: 324–330.
   PubMed Web of Science ®Google Scholar
• Yang ZG, Chen AQ, Yu SD (2005): Research progress of pharmacological actions of Panax notoginseng. Shanghai J Trad Chinese Med 39: 59–62.
   Google Scholar